VLVbio

    OverviewSuggest Edit

    VLVbio is a biotechnology company. It is devoted to the invention and development of PEVIVA Keratin 18 biomarkers M30 and M65 for the measurement of epithelial cell death in liver disease and oncology. VLVbio's products are used in the fields of hepatology, oncology, and toxicology.
    TypePrivate
    Founded2013
    Websitevlvbio.com

    Latest Updates

    Employees (est.) (Nov 2021)9
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    VLVbio Financials and Metrics

    Summary Metrics

    Founding Date

    2013

    VLVbio Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    93/100

    SecurityScorecard logo

    VLVbio Online and Social Media Presence

    Embed Graph

    VLVbio Frequently Asked Questions

    • When was VLVbio founded?

      VLVbio was founded in 2013.

    • How many employees does VLVbio have?

      VLVbio has 9 employees.

    • Who are VLVbio competitors?

      Competitors of VLVbio include MiraDx, Proteona and Femtogenix.